Hallak JEC - Search Results

1

Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022).

Souza JDR, Pacheco JC, Rossi GN, de-Paulo BO, Zuardi AW, Guimarães FS, Hallak JEC, Crippa JA, Dos Santos RG. Souza JDR, et al. Among authors: hallak jec. Pharmaceutics. 2022 Nov 25;14(12):2598. doi: 10.3390/pharmaceutics14122598. Pharmaceutics. 2022. PMID: 36559092 Free PMC article. Review.

2

Factor structure of Bech's version of the Brief Psychiatric Rating Scale in Brazilian patients.

Crippa JA, Sanches RF, Hallak JE, Loureiro SR, Zuardi AW. Crippa JA, et al. Braz J Med Biol Res. 2002 Oct;35(10):1209-13. doi: 10.1590/s0100-879x2002001000014. Epub 2002 Oct 13. Braz J Med Biol Res. 2002. PMID: 12424494 Free article.

3

Diagnostic profile of inpatients as a determinant of length of stay in a general hospital psychiatric unit.

Hallak JE, Crippa JA, Vansan G, Zuardi AW. Hallak JE, et al. Braz J Med Biol Res. 2003 Sep;36(9):1233-40. doi: 10.1590/s0100-879x2003000900014. Epub 2003 Aug 19. Braz J Med Biol Res. 2003. PMID: 12937791 Free article.

4

Olanzapine for recurrent aggression in a patient with temporal lobe epilepsy who had temporal lobectomy.

Hallak JE, Dursun SM, Guarnieri R, Almeida E, Rezeck K, Crippa JA, Sakamoto AC, Zuardi AW, Deakin JF. Hallak JE, et al. J Psychopharmacol. 2003 Sep;17(3):350-1. doi: 10.1177/02698811030173020. J Psychopharmacol. 2003. PMID: 14513930

5

Interictal SPECT in patients with mesial temporal lobe epilepsy and psychosis: a case-control study.

Guarnieri R, Wichert-Ana L, Hallak JE, Velasco TR, Walz R, Kato M, Alexandre V Jr, Terra-Bustamante VC, Bianchin MM, Zuardi AW, Deakin JF, Sakamoto AC. Guarnieri R, et al. Psychiatry Res. 2005 Jan 30;138(1):75-84. doi: 10.1016/j.pscychresns.2004.10.003. Psychiatry Res. 2005. PMID: 15708303

6

Cannabidiol monotherapy for treatment-resistant schizophrenia.

Zuardi AW, Hallak JE, Dursun SM, Morais SL, Sanches RF, Musty RE, Crippa JA. Zuardi AW, et al. J Psychopharmacol. 2006 Sep;20(5):683-6. doi: 10.1177/0269881106060967. Epub 2006 Jan 9. J Psychopharmacol. 2006. PMID: 16401651 Clinical Trial.

7

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.

Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimarães FS. Zuardi AW, et al. Braz J Med Biol Res. 2006 Apr;39(4):421-9. doi: 10.1590/s0100-879x2006000400001. Epub 2006 Apr 3. Braz J Med Biol Res. 2006. PMID: 16612464 Free article. Review.

8

Cannabidiol for the treatment of psychosis in Parkinson's disease.

Zuardi AW, Crippa JA, Hallak JE, Pinto JP, Chagas MH, Rodrigues GG, Dursun SM, Tumas V. Zuardi AW, et al. J Psychopharmacol. 2009 Nov;23(8):979-83. doi: 10.1177/0269881108096519. Epub 2008 Sep 18. J Psychopharmacol. 2009. PMID: 18801821

9

Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania.

Valvassori SS, Elias G, de Souza B, Petronilho F, Dal-Pizzol F, Kapczinski F, Trzesniak C, Tumas V, Dursun S, Chagas MH, Hallak JE, Zuardi AW, Quevedo J, Crippa JA. Valvassori SS, et al. J Psychopharmacol. 2011 Feb;25(2):274-80. doi: 10.1177/0269881109106925. Epub 2009 Nov 25. J Psychopharmacol. 2011. PMID: 19939866

10

Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD).

Hallak JE, Machado-de-Sousa JP, Crippa JA, Sanches RF, Trzesniak C, Chaves C, Bernardo SA, Regalo SC, Zuardi AW. Hallak JE, et al. Braz J Psychiatry. 2010 Mar;32(1):56-61. doi: 10.1590/s1516-44462010000100011. Braz J Psychiatry. 2010. PMID: 20339735 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

260 results

Search Page